SG Capital Dumps Nearly 732,000 Haemonetics Shares Worth $59.1 Million

SG Capital Management LLC significantly reduced its position in Haemonetics (NYSE:HAE) by selling 731,892 shares, decreasing its allocation from 4.7% to 0.8% of its AUM. This divestment follows HAE's 14.1% share price decline over the past year, underperforming the S&P 500, and a 5% revenue slide in its recent fiscal second quarter. While HAE shares saw a 35% jump post-earnings due to slightly improved full-year guidance, SG Capital's substantial reduction suggests a strategic move to exit given the company's underlying performance challenges.

Analysis

SG Capital Management LLC significantly reduced its position in Haemonetics (NYSE:HAE) during Q3, selling 731,892 shares and decreasing its AUM allocation from 4.7% to 0.8%. This substantial divestment, valued at approximately $45.3 million, positions HAE outside the fund's top five holdings, signaling a strategic shift away from the company.

Haemonetics' shares have underperformed, declining 14.1% over the past year and trailing the S&P 500 by 27.5 percentage points. The company reported a 5% revenue slide in its fiscal Q2, or 1.8% excluding currency and divestitures, indicating ongoing operational challenges.

Despite the revenue decline, an improved full-year adjusted revenue guidance (1% decline to 2% increase) led to a 35% share price jump post-earnings. However, the aggressive reduction by SG Capital, even after this positive market reaction, suggests persistent institutional concerns regarding HAE's fundamental trajectory and long-term growth prospects.

Key Decisions for Investors

• Monitor Haemonetics' (HAE) future revenue growth and management's execution against revised guidance, as historical performance indicates underlying weakness.
• Evaluate the implications of significant institutional divestment, like SG Capital's, as it may signal fundamental concerns not fully priced in.
• Consider the stock's volatility, evidenced by the 35% post-earnings jump against long-term underperformance, and assess risk exposure accordingly.